Togo vs United Kingdom of Great Britain and Northern Ireland: Pneumococcal conjugate second or third-dose vaccines (PCVc)

Togo
89.0%
in 2025
United Kingdom of Great Britain and Northern Ireland
89.0%
in 2025
Togo rank
72nd
United Kingdom of Great Britain and Northern Ireland rank
72nd

Pneumococcal conjugate second or third-dose vaccines (PCVc) over time

  • Togo
  • United Kingdom of Great Britain and Northern Ireland
020406080100200820162025

How they compare

Togo currently reports 89.0% against 89.0% in United Kingdom of Great Britain and Northern Ireland, a difference of 0.0%.

Across all 18 years both countries report, United Kingdom of Great Britain and Northern Ireland has been ahead every year.

Togo ranks 72nd and United Kingdom of Great Britain and Northern Ireland ranks 72nd of 194 countries.

United Kingdom of Great Britain and Northern Ireland has averaged higher in every one of the 3 decades both report.

Head to head by decade

Decade Togo United Kingdom of Great Britain and Northern Ireland Difference Ahead
2000s 0.0% 0.0% 0.0%
2010s 43.9% 91.7% 47.8% United Kingdom of Great Britain and Northern Ireland
2020s 89.0% 89.8% 0.8% United Kingdom of Great Britain and Northern Ireland

Averages of every year both report within each decade.

Frequently asked questions

Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc), Togo or United Kingdom of Great Britain and Northern Ireland?
Togo, at 89.0% against 89.0% in United Kingdom of Great Britain and Northern Ireland as of 2025.
What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) between Togo and United Kingdom of Great Britain and Northern Ireland?
0.0%, with Togo ahead.
How many years of comparable data are there for Togo and United Kingdom of Great Britain and Northern Ireland?
18 years are reported by both, from 2008 to 2025.
How do Togo and United Kingdom of Great Britain and Northern Ireland rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc)?
Togo ranks 72nd and United Kingdom of Great Britain and Northern Ireland ranks 72nd of 194 countries.
Where does this data come from?
World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Togo vs United Kingdom of Great Britain and Northern Ireland: Pneumococcal conjugate second or third-dose vaccines (PCVc). Statizoid, drawing on World Health Organization, Global Health Observatory. Retrieved 22 August 2026, from https://health.statizoid.com/compare/pneumococcal-conjugate-second-or-third-dose-vaccines-pcvc-immunization-coverage-by-the/togo/united-kingdom/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY-NC-SA 3.0 IGO (WHO); please keep the attribution.

<a href="https://health.statizoid.com/compare/pneumococcal-conjugate-second-or-third-dose-vaccines-pcvc-immunization-coverage-by-the/togo/united-kingdom/">Togo vs United Kingdom of Great Britain and Northern Ireland: Pneumococcal conjugate second or third-dose vaccines (PCVc)</a> — Statizoid

About this data

Indicator
Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC)
Source
World Health Organization, Global Health Observatory
Licence
CC BY-NC-SA 3.0 IGO (WHO)
Coverage
206 places, 3,705 data points, 2008–2025
Last refreshed